Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-02 Sale |
2022-11-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
4,730 | $0.9829 | $4,649 | 127,080 (Direct) |
View |
| 2022-11-02 Sale |
2022-11-03 4:15 pm |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
3,681 | $0.9829 | $3,618 | 320,487 (Direct) |
View |
| 2022-11-02 Sale |
2022-11-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
1,766 | $0.98289 | $1,736 | 34,821 (Indirect Direct) |
View |
| 2022-11-02 Sale |
2022-11-03 4:15 pm |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
4,579 | $0.983 | $4,501 | 133,579 (Direct) |
View |
| 2022-11-02 Sale |
2022-11-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
4,261 | $0.9829 | $4,188 | 140,566 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-04 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
6 | $1.29 | $8 | 21,608 (Indirect Direct) |
View |
| 2022-09-02 Sale |
2022-09-06 4:15 pm |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
2,545 | $1.2 | $3,054 | 160,203 (Direct) |
View |
| 2022-09-02 Sale |
2022-09-06 4:15 pm |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
2,308 | $1.2 | $2,770 | 143,437 (Direct) |
View |
| 2022-09-02 Sale |
2022-09-06 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
1,616 | $1.2 | $1,939 | 53,495 (Indirect Direct) |
View |
| 2022-09-02 Sale |
2022-09-06 4:15 pm |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
2,234 | $1.2 | $2,681 | 339,544 (Direct) |
View |
| 2022-09-02 Sale |
2022-09-06 4:15 pm |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
2,234 | $1.2 | $2,681 | 149,786 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-03 4:16 pm |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
4,654 | $1.4609 | $6,799 | 135,329 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
4,330 | $1.4609 | $6,326 | 142,309 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-03 4:15 pm |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
3,802 | $1.461 | $5,555 | 321,339 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
4,807 | $1.4611 | $7,024 | 129,055 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
1,809 | $1.461 | $2,643 | 34,790 (Indirect Direct) |
View |
| 2022-07-05 Sale |
2022-07-06 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
7 | $2.71 | $19 | 18,078 (Indirect Direct) |
View |
| 2022-06-02 Sale |
2022-06-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
1,722 | $0.64249 | $1,106 | 53,354 (Indirect Direct) |
View |
| 2022-06-02 Sale |
2022-06-03 4:15 pm |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
2,327 | $0.6424 | $1,495 | 146,425 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
2,650 | $0.6425 | $1,703 | 158,704 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
2,403 | $0.6424 | $1,544 | 140,303 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-03 4:15 pm |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
2,327 | $0.6424 | $1,495 | 337,206 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 4:15 pm |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
3,733 | $1.9698 | $7,353 | 322,406 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 4:15 pm |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
4,570 | $1.9698 | $9,002 | 137,248 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
1,776 | $1.9698 | $3,498 | 34,909 (Indirect Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
4,252 | $1.9698 | $8,376 | 144,227 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
4,570 | $1.9698 | $9,002 | 131,203 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-05 4:16 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
7 | $2.66 | $19 | 14,625 (Indirect Direct) |
View |
| 2022-03-02 Sale |
2022-03-03 4:16 pm |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
10,706 | $1.866 | $19,977 | 224,074 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-03 4:15 pm |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
10,770 | $1.866 | $20,097 | 415,892 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
10,945 | $1.866 | $20,423 | 238,232 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
7,826 | $1.866 | $14,603 | 140,668 (Indirect Direct) |
View |
| 2022-03-02 Sale |
2022-03-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
10,706 | $1.866 | $19,977 | 218,028 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:17 pm |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
4,514 | $1.9397 | $8,756 | 138,486 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:16 pm |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
4,442 | $1.9397 | $8,616 | 315,971 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
2,118 | $1.9396 | $4,108 | 30,586 (Indirect Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:15 pm |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
5,436 | $1.9396 | $10,544 | 125,666 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:15 pm |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
5,436 | $1.9397 | $10,544 | 131,711 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 4:15 pm |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
7 | $2.75 | $19 | 7,102 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-01 Exercise |
2022-11-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
10,248 | $0 | 127,080 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
8,374 | $0 | 320,487 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
3,555 | $0 | 34,821 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
10,248 | $0 | 133,579 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
8,374 | $0 | 140,566 (Direct) |
View |
| 2022-10-01 Exercise |
2022-10-04 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
15 | $0 | 21,608 (Indirect) |
View |
| 2022-09-01 Exercise |
2022-09-06 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
5,063 | $0 | 160,203 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-06 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
5,063 | $0 | 143,437 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-06 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
3,404 | $0 | 53,495 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-06 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
5,063 | $0 | 339,544 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-06 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
5,063 | $0 | 149,786 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 4:16 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
10,249 | $0 | 135,329 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
8,374 | $0 | 142,309 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
8,374 | $0 | 321,339 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
10,249 | $0 | 129,055 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
3,557 | $0 | 34,790 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-06 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
16 | $0 | 18,078 (Indirect) |
View |
| 2022-06-01 Exercise |
2022-06-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
3,403 | $0 | 53,354 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
5,062 | $0 | 146,425 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
5,062 | $0 | 158,704 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
5,062 | $0 | 140,303 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
5,062 | $0 | 337,206 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
8,374 | $0 | 322,406 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
10,248 | $0 | 137,248 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
3,555 | $0 | 34,909 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
8,374 | $0 | 144,227 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
10,248 | $0 | 131,203 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:16 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
16 | $0 | 14,625 (Indirect) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:16 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
81,000 | $0 | 224,074 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 4:16 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
20,813 | $0 | 224,074 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
81,000 | $0 | 415,892 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
20,938 | $0 | 415,892 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:15 pm |
N/A 2032-03-01 |
Clovis Oncology Inc. | CLVS | MAHAFFY PATRICK J See Remarks |
380,000 | $0 | 380,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
81,000 | $0 | 238,232 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
20,938 | $0 | 238,232 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
87,380 | $0 | 140,668 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
13,916 | $0 | 140,668 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
81,000 | $0 | 218,028 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
20,813 | $0 | 218,028 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:17 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Rolfe Lindsey See Remarks |
8,375 | $0 | 138,486 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:16 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | IVERS-READ GILLIAN C See Remarks |
8,375 | $0 | 315,971 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
3,558 | $0 | 30,586 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Gross Paul Edward See Remarks |
10,250 | $0 | 125,666 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | MUEHL DANIEL W See Remarks |
10,250 | $0 | 131,711 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 4:15 pm |
N/A N/A |
Clovis Oncology Inc. | CLVS | Harding Thomas C. See Remarks |
16 | $0 | 7,102 (Indirect) |
View |